ImmunoPharm #2 Flashcards

1
Q

Immunosuppressants
▪ Immunosuppressatory drugs act by a _____ of mechanisms
▪ These drugs interfere with combinations of critical pathways in the ___________ cascade
▪ “Cytotoxic” drugs: cause cell _______, _________, or impaired ________.
▪ “Lymphocyte” drugs: ______ immune system by inhibiting function or proliferation of _______, production of ______ etc
▪ Glucocorticoids: have many effects upon _____ and ______ immunity

A

variety, inflammatory, necrosis, apoptosis, proliferation, suppress, lymphocytes, cytokines, innate, adaptive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Immunosuppressants: Classification

A
  1. Antimetabolites
  2. Inhibitors of Matrix Metalloproteinase (MMPs)
  3. Other immunomodulators
  4. Inhibitors of Cytokines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antimetabolites
➢ _______ synthesis inhibitors
✓ Azathioprine (ImuranR), ✓Mycophenolic acid
OR
➢ _______ synthesis inhibitor
B: ✓ Leflunomide

A

Purine, Pyrimidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

An Inhibitors of Matrix Metalloproteinase (MMPs) is the drug?

A

Tetracycline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Other Immunomodulators
➢ _____ Therapy (chrysotherapy)
✓ Auranofin
✓ Gold sodium thiomalate
OR
➢__________

A

Gold, Niacinamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

❑ Inhibitors of Cytokines
➢ IL-__ inhibitors
✓ Cyclosporine
✓ Tacrolimus
OR
➢ _______ ________ ________ ____ (____) inhibitor
✓ Pentoxyfylline

A

2, Tumor-necrosis factor-α (TNFα)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Azathioprine (________): a ________ Synthesis Inhibitor

A

ImuranR, Purine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Antimetabolic drugs inhibit cellular synthesis of _______ _____ that are required for RNA and DNA synthesis resulting in cellular ______ and ______ arrest

A

nucleic acids, proliferation, function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Azathioprine MOA: ______ DNA synthesis of __- and __-lymphocytes

Blocks ____ signaling on ___-cells resulting in impaired _____ synthesis

A

inhibits, B, T, CD28, T, RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Azathioprine Uses
In conjunction with _______ to treat ______-mediated diseases such as?

A

steroids, immune

▪ Immune-mediated hemolytic anemia = dogs
▪ Immune-mediated thrombocytopenia
▪ Colitis and skin disease
▪ Myasthenia gravis
▪ Inflammatory bowel disease
▪ Immune-mediated inflammatory conditions and perianal fistulas in dogs
▪ Autoimmune skin disease in horses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Azathioprine PK
▪ Azathioprine is a _______, well absorbed by the gut
▪ Several metabolic steps to become ___
▪ Detoxification is important, cats and ____% dogs are ____ in enzymes
▪ Do not give to _____

A

prodrug, active, 10, low, cats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Azathioprine Adverse Effects
▪ _________ _______ suppression
▪ Fatal ______ and ________
▪ Increase risk for _____
▪ ____________ and ___ pancreatitis
▪ _________ (changes in genetic material), __________ (reversible structural malfunctions in fetus) and __________ (cancerous tumors) effects

A

Bone marrow, leukopenia, thrombocytopenia, infection, Hepatotoxicity, acute, Mutagenic, teratogenic, carcinogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Leflunomide: a ________ Synthesis Inhibitor
MOA?

Inhibits _________ enzyme necessary for ____ ________ ______ synthesis
Affects particularly ___- and ____-lymphocytes DNA synthesis

A

Pyrimidine, mitochondrial, de novo pyrimidine, B-, T-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leflunomide Uses

A

▪ Immune-mediated hemolytic anemia
▪ Immune-mediated thrombocytopenia
▪ Immune-mediated polymyositis
▪ Multifocal nonsuppurative encephalitis/meningomyelitis
▪ Evan’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Leflunomide PK

▪ OP: good _________ of ____ metabolite
▪ High ______ bound
▪ _____ metabolism
▪ Conversion of Leflunomide to a toxic metabolite is ______ in cats then dogs

A

bioavailability, active, protein, Liver, slower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Leflunomide Adverse Effects
▪ Uncommon in ____
▪ May include ___ disturbances
▪ ______

A

dogs, GI, Anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Polymyositis is a relatively common ________ disease in ____ that causes muscle ________ and ______.
There are 3 main causes of polymyositis in dogs:
▪ Infectious agents (?)
▪ Immune-mediated ( ______diseases)
▪ ______________ causes (tumors affecting muscles, ex. Lymphoma)

A

inflammatory, dogs, weakness, fatigue

bacteria, viruses, protozoa or parasites, autoimmune, Paraneoplastic

18
Q

What are the signs and symptoms of polymyositis in dogs?
▪ __________ weakness that worsens with ______
▪ Muscle _____ and ___
▪ _______ (lack of _____)
▪ Exercise _________
▪ Muscle ___________

A

Generalized, exercise, swelling, pain, Anorexia, appetite, intolerance, wasting

19
Q

Treatment for polymyositis:

A

Azathioprine
Leflunomide
Cyclosporine
Prednisone
Polymyositis In Dogs: Causes, Symptoms And Treatment

20
Q

Cyclosporine: an IL-__ Inhibitor MOA

Cyclophillin is a mitochondrial protein expressed in ___ cells, important for protein ______. It bins to receptor in mitchondria of t cells.

Calcineurin is a protein phosphatase that activates _________ by then phosphorylating and translocating to the nucleus. It is important for dephosphorylation of NFAT__ –> NFAT__ which enters nucleus and activates IL-__.

___________ competes with ______ to bind to receptors and interfere with IL-2 proliferation.

A

2, T, folding, nuclear factor NF-ATc, c, n, 2, Cyclosporine, cyclophillin

21
Q

Cyclosporine: an IL-2 Inhibitor (cont)
Pharmacological effects?
▪ T-lymphocytes:
Decrease production of IL-?
Decrease production of _____
Decrease TNF__
Decrease proliferation of both CD__+ and CD__+ lymphocytes
Increase TGF__ (inhibits IL-__)
▪ Mast cells: Decrease _______ release in canine mast cells

A

2, IL-3, and IL-4, G-CSF, α, 4, 8, β, 2, histamine

22
Q

Cyclosporine Uses?
Uses:
▪ ________________ ________: topical application , increased ____ production
▪ _____________ ______: elimination/reduction in ____, OP, __-__ months of treatment
▪ ______: in conjunction with glucocorticoids

A

Keratoconjunctivitis sicca, tear, Perianal fistulas, size, 2-3, IMHA

23
Q

Cyclosporine PK?
PK:
▪ ____, not well ______
▪ Distribution: ?
▪ ____ metabolism
▪ ____/____ excretion

A

OP, absorbed,
liver, fat, red blood cell and lymphocytes
Liver,
bile/urine

24
Q

Cyclosporine Adverse Effects?
Adverse effects:
▪ ____ disturbances
▪ Gingival ________
▪ ___________ in dogs
▪ Viral infections in ____

A

GI, hyperplasia, Papillomatosis, cats

25
Tacrolimus (FK-506): an IL-2 Inhibitor MOA?
Tacrolimus, also called FK506, prevents the dephosphorylation of NF-AT by binding to FKBP12 --> Prevents IL proliferation
26
Tacrolimus Therapeutic uses?
▪ Keratoconjunctivitis sicca ▪ Localized topical treatment of immune-mediated dermatological disease
27
Tacrolimus PK
Since it applied topically, very little is absorbed systemically
28
Tacrolimus Adverse effects
Local irritation
29
Pentoxyfylline (PTX): TNFα inhibitor MOA: ? __________ the release and production of the _______ _____, suppresses the production of __________-_______ factor, and inhibits its action on _______.
downregulates, profibrotic TNF, platelet-activating, neutrophils
30
Pentoxyfylline (PTX): TNFα inhibitor Uses: ?
Canine skin diseases: ▪ Vasculitis ▪ Dermatomyositis ▪ Contact allergy ▪ Atopic dermatitis ▪ Vaccine-induced ischemic dermatitis Equine: ▪ Systemic inflammatory response syndrome ▪ Caudal heal syndrome
31
Pentoxyfylline PK ? PK: rapid absorption in ____ Adverse effects? Adverse effects: ___ ▪ __ disturbance ▪ CNS ?
dogs, Rare, GI, excitement/nervousness
32
Tetracyclines are a broad spectrum antibiotics
33
Tetracyclines and tetracycline derivatives are able to inhibit ______ activity, _____________ of their anti-microbial action. MMPs: play a major role in cell ?
MMP, independent proliferation, diffferentiaon, migration, apoptosis, angiogenesis, and host defense.
34
Describe the duration of action of the following drugs?
See below
35
Tetracyclines uses?
▪ Systemic ▪ Topical ophthalmic
36
Tetracycline adverse effects?
▪ Vomiting, diarrhea ▪ Kidney damage ▪ Liver damage ▪ Loss of appetite
37
➢ Gold Therapy (chrysotherapy) ✓ __________ ✓ _________ ____________ _________ 1. MOA: 2. Uses: ? 3. Adverse effects: ?
Auranofin, Gold sodium thiomalate 1. Not completely understood [ inhibition of phagocytes (macrophages) and T-cells] 2. Idiopathic polyarthritis Rheumatoid arthritis Pemphigus foliaceus (PF) Chronic gingivitis/stomatitis 3. ▪ Stomatitis ▪ Skin lesions ▪ Hepatic necrosis ▪ Renal toxicity ▪ GI disturbances
38
➢ Niacinamide is a vitamin _____ (nutritional supplement or with other medications) MOA: ? Uses: particularly in dogs? PK: ▪ OP, well ______ ▪ ______ distributed in the body ▪ ____ metabolism ▪ _____ excretion Adverse effects: ▪ ___ disturbances ▪ _____ ▪ Elevation of _____ enzymes
1. B3 2. poor understood (blocks mast cell degranulation and inhibits protease release from leukocytes) 3. ▪ Discoid lupus erythematosus ▪ Pemphigus erythematosus ▪ Pemphigus foliaceus (PF) ▪ Autoimmune diseases absorbed, Widely, Liver, Urine, GI, Lethargy, hepatic
39
Do not need to know
Do not need to know
40
Autoimmune disorders ▪ Immune system attacks the ______ cells in the body by mistake ▪ The body has lost its ability to differentiate between antigens on its ______ cells and antigens on ______ cells ▪ Antibodies attack _____-antigens ▪ ______ is a major mechanism of tissue damage Cause: ?
healthy, own, foreign, self, Inflammation, Genetic Environmental
41
Hemolytic Anemia in Dogs ▪ Autoimmune hemolytic anemia (AIHA) is an immune system disease, in which the body attacks and destroys its own _____ (_______). ▪ Immune-Mediated Hemolytic Anemia (IMHA) causes severe _____ in dogs and is associated with considerable _____ and _____ ▪ IMHA is the most common autoimmune disease in _____
RBCs, hemolysis, anemia, morbidity, mortality, dogs
42
Management of IMHA: Controlling the immune response:
Skipped?